Screening psychiatric patients for illicit drug use disorders and problems

Clinical Psychology Review

Volumn 28, Issue 4, 2008, Pages 578-591

  Tiet, Quyen Q ^a   Finney, John W ^a   Moos, Rudolf H ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ILLICIT DRUG;

CLINICAL ASSESSMENT TOOL; DIAGNOSTIC ACCURACY; DRUG ABUSE; DRUG SCREENING; EARLY DIAGNOSIS; EVALUATION; GENDER; HUMAN; MENTAL PATIENT; OUTCOME ASSESSMENT; REVIEW; SENSITIVITY AND SPECIFICITY; VALIDITY;

ALCOHOL-RELATED DISORDERS; HUMANS; MASS SCREENING; MENTAL DISORDERS; SOCIAL BEHAVIOR DISORDERS; STREET DRUGS; SUBSTANCE ABUSE DETECTION; SUBSTANCE-RELATED DISORDERS;

EID: 40749122970     PISSN: 02727358     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cpr.2007.08.002     Document Type: Review

References (88)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. (4th ed.) (1994), Author, Washington, DC
2. Ananth J., Vandewater S., Kamal M., Brodsky A., Gamal R., and Miller M. Missed diagnosis of substance abuse in psychiatric patients. Hospital and Community Psychiatry 40 3 (1989) 297-299
3. Barrowclough C., Haddock G., Tarrier N., Lewis S.W., Moring J., O'Brien R., et al. Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders. The American Journal of Psychiatry 158 10 (2001) 1706-1713
4. Barry K.L., Fleming M.F., Greenley J.R., Kropp S., and Widlak P. Characteristics of persons with severe mental illness and substance abuse in rural areas. Psychiatric Services 47 1 (1996) 88-90
5. Bartels S.J., Teague G.B., Drake R.E., Clark R.E., Bush P.W., and Noordsy D.L. Substance abuse in schizophrenia: service utilization and costs. Journal of Nervous and Mental Disease 181 4 (1993) 227-232
6. Bastiaens L., Riccardi K., and Sakhrani D. The RAFFT as a screening tool for adult substance use disorders. The American Journal of Drug and Alcohol Abuse 28 4 (2002) 681-691
7. Beckman L.J., and Amaro H. Personal and social difficulties faced by women and men entering alcoholism treatment. Journal of Studies on Alcohol 47 2 (1986) 135-145
8. Berman A.H., Bergman H., Palmstierna T., and Schlyter F. Evaluation of the Drug Use Disorders Identification Test (DUDIT) in criminal justice and detoxification settings and in a Swedish population sample. European Addiction Research 11 (2005) 22-31
9. Blow F.C., McCarthy J.F., Valenstein M., Austin K., and Gillon L. Care for veterans with psychosis in the Veterans Health Administration. FY04: 6th Annual National Psychosis Registry Report. Ann Arbor, MI: Health Services Research and Development Center of Excellence, Serious Mental Illness Treatment Research and Evaluation Center (SMITREC) (2005), Department of Veterans Affairs
10. Bradley K.A., Kivlahan D.R., Zhou X.H., Sporleder J.L., Epler A.J., McCormick K.A., et al. Using alcohol screening results and treatment history to assess the severity of at-risk drinking in Veterans Affairs primary care patients. Alcoholism, Clinical and Experimental Research 28 3 (2004) 448-455
11. Brown R.L., Leonard T., Saunders L.A., and Papasouliotis O. A two-item screening test for alcohol and other drug problems. Journal of Family Practice 44 2 (1997) 151-160
12. Brown R.L., and Rounds L.A. Conjoint screening questionnaires for alcohol and other drug abuse: criterion validity in a primary care practice. Wisconsin Medical Journal 94 3 (1995) 135-140
13. Bryer J.B., Martines K.A., and Dignam M.A. Millon clinical multiaxial inventory alcohol and drug abuse scale and the identification of substance-abuse patients. Psychological Assessment 2 (1990) 438-441
14. Calsyn D.A., Saxon A.J., and Daisy F. Validity of the MCMI drug abuse scale with drug abusing and psychiatric samples. Journal of Clinical Psychology 46 2 (1990) 244-246
15. Calsyn D.A., Saxon A.J., and Daisy F. Validity of the MCMI drug abuse scale varies as a function of drug choice, race, and axis II subtypes. American Journal of Drug and Alcohol Abuse 17 2 (1991) 153-159
16. Carey K.B. Treatment of substance abuse with schizophrenia. In: Lehman A.F., and Dixon L. (Eds). Double jeopardy: Chronic mental illness and substance abuse (1995), Harwood, London 85-108
17. Carey K.B., Roberts L.J., Kivlahan D.R., Carey M.P., and Neal D.J. Problems assessment for substance using psychiatric patients: Development and initial psychometric evaluation. Drug and Alcohol Dependence 75 1 (2004) 67-77
18. Caton C.L., Shrout P.E., Eagle P.F., Opler L.A., Felix A., and Dominguez B. Risk factors for homelessness among schizophrenic men: a case-control study. American Journal of Public Health 84 2 (1994) 265-270
19. Center for Mental Health Services. Making a difference: Interim status report of the McKinney research demonstration program for homeless mentally ill adults. Substance Abuse and Mental Health Services Administration (1994), U.S. Department of Health and Human Services, Rockville, MD
20. Center for Substance Abuse Treatment. Results from the 2004 National Survey on Drug Use and Health: National findings. Substance Abuse and Mental Health Services Administration (2005), Department of Health and Human Services
21. Center for Substance Abuse Treatment. Substance abuse treatment for persons with co-occurring disorders. Treatment Improvement Protocol (TIP) Series 42. DHHS Publication No. (SMA) 05-3922 (2005), Substance Abuse and Mental Health Services Administration, Rockville, MD
22. Cherpitel C.J. Screening for alcohol problems in the emergency room: A rapid alcohol problems screen. Drug and Alcohol Dependence 40 2 (1995) 133-137
23. Cherpitel C.J., and Bazargan S. Screening for alcohol problems: Comparison of the audit, RAPS4 and RAPS4-QF among African American and Hispanic patients in an inner city emergency department. Drug and Alcohol Dependence 71 3 (2003) 275-280
24. Cherpitel C.J., and Borges G. Screening for drug use disorders in the emergency department: Performance of the Rapid Drug Problems Screen (RDPS). Drug and Alcohol Dependence 74 2 (2004) 171-175
25. Clark R.E., Teague G.B., Ricketts S.K., Bush P.W., Xie H., McGuire T.G., et al. Cost-effectiveness of assertive community treatment versus standard case management for persons with co-occurring severe mental illness and substance use disorders. Health Services Research 33 5 Pt 1 (1998) 1285-1308
26. Cocco K.M., and Carey K.B. Psychometric properties of the drug abuse screening test in psychiatric outpatients. Psychological Assessment 10 4 (1998) 408-414
27. Colpaert F.C., Niemegeers C.J., and Janssen P.A. Neuroleptic interference with the cocaine cue: Internal stimulus control of behavior and psychosis. Psychopharmacology 58 3 (1987) 247-255
28. Cottler L.B., Robins L.N., and Helzer J.E. The reliability of the CIDI-SAM: A comprehensive substance abuse interview. British Journal of Addiction 84 7 (1989) 801-814
29. Dickey B., and Azeni H. Persons with dual diagnoses of substance abuse and major mental illness: Their excess costs of psychiatric care. American Journal of Public Health 86 7 (1996) 973-977
30. Drake R.E., McHugo G.J., Clark R.E., Teague G.B., Xie H., Miles K., et al. Assertive community treatment for patients with co-occurring severe mental illness and substance use disorder: A clinical trial. The American Journal of Orthopsychiatry 68 2 (1998) 201-215
31. Drake R.E., Mueser K.T., Clark R.E., and Wallach M.A. The course, treatment, and outcome of substance disorder in persons with severe mental illness. American Journal of Orthopsychiatry 66 1 (1996) 42-51
32. Drake R.E., Osher F.C., Noordsy D.L., Hurlbut S.C., Teague G.B., and Beaudette M.S. Diagnosis of alcohol use disorders in schizophrenia. Schizophrenia Bulletin 16 1 (1990) 57-67
33. Drake R.E., and Wallach M.A. Substance abuse among the chronic mentally ill. Hospital and Community Psychiatry 40 10 (1989) 1041-1046
34. Ewing J.A. Detecting alcoholism. The CAGE questionnaire. JAMA 252 14 (1984) 1905-1907
35. Feldstein S.W., and Miller W.R. Does subtle screening for substance abuse work? A review of the Substance Abuse Subtle Screening Inventory (SASSI). Addiction 102 (2006) 41-50
36. Fiellin D.A., Reid M.C., and O'Connor P.G. Screening for alcohol problems in primary care: A systematic review. Archives of Internal Medicine 160 13 (2000) 1977-1989
37. First M.B., Gibbon M., Spitzer R.L., and Williams J.B.W. User's guide for structured clinical interview for DSM-IV Axis I disorders-Research version (SCID-I, Version 2.0, February 1996 FINAL Version) (1996), Biometric Research, New York
38. Garnick D.W., Hendricks A.M., Drainoni M., Horgan C.M., and Comstock C. Private sector coverage of people with dual diagnoses. Journal of Mental Health Administration 23 3 (1996) 317-328
39. Grant B.F., Hasin D.S., and Harford T.C. Screening for current drug use disorders in alcoholics: An application of receiver operating characteristic analysis. Drug and Alcohol Dependence 21 2 (1988) 113-125
40. Hien D.A., Cohen L.R., Miele G.M., Litt L.C., and Capstick C. Promising treatments for women with comorbid PTSD and substance use disorders. The American Journal of Psychiatry 161 8 (2004) 1426-1432
41. Kellogg S.H., McHugh P.F., Bell K., Schluger J.H., Schluger R.P., LaForge K.S., et al. The Kreek-McHugh-Schluger-Kellogg scale: A new, rapid method for quantifying substance abuse and its possible applications. Drug and Alcohol Dependence 69 2 (2003) 137-150
42. Kessler R.C., McGonagle K.A., Zhao S., Nelson C.B., Hughes M., Eshleman S., et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Archives of General Psychiatry 51 1 (1994) 8-19
43. Knott A., Dieperink E., Willenbring M.L., Heit S., Durfee J.M., Wingert M., et al. Integrated psychiatric/medical care in a chronic hepatitis C clinic: Effect on antiviral treatment evaluation and outcomes. American Journal of Gastroenterology 101 (2006) 2254-2262
44. Latimer W.W., Winters K.C., and Stinchfield R.D. Screening for drug abuse among adolescents in clinical and correctional setting using the problem-oriented screening instrument for teenagers. American Journal of Drug and Alcohol Abuse 23 1 (1997) 79-98
45. Lazowski L.E., Miller F.G., Boye M.W., and Miller G.A. Efficacy of the Substance Abuse Subtle Screening Inventory-3 (SASSI-3) in identifying substance dependence disorders in clinical settings. Journal of Personality Assessment 71 1 (1998) 114-128
46. Linszen D.H., Dingemans P.M., and Lenior M.E. Cannabis abuse and the course of recent-onset schizophrenic disorders. Archives of General Psychiatry 51 4 (1994) 273-279
47. Maisto S.A., Carey M.P., Carey K.B., Gordon C.M., and Gleason J.R. Use of the AUDIT and the DAST-10 to identify alcohol and drug use disorders among adults with a severe and persistent mental illness. Psychological Assessment 12 2 (2000) 186-192
48. Marsh J.C., Colten M.E., and Tucker M.B. Women's use of drugs and alcohol: New perspective. Journal of Social Issues 38 (1982) 1-8
49. Marsh D.T., Stile S.A., Stoughton N.L., and Trout-Landen B.L. Psychopathology of opiate addiction: Comparative data from the MMPI and MCMI. American Journal of Drug and Alcohol Abuse 14 1 (1988) 17-27
50. McPherson T.L., and Hersch R.K. Brief substance use screening instruments for primary care settings: A review. Journal of Substance Abuse Treatment 18 2 (2000) 193-202
51. Milby J.B., Schumacher J.E., McNamara C., Wallace D., Usdan S., McGill T., et al. Initiating abstinence in cocaine abusing dually diagnosed homeless persons. Drug & Alcohol Dependence 60 1 (2000) 55-67
52. Miller F.G., and Lazowski L.E. The Adult SASSI-3 Manual (1999), SASSI Institute, Springville, IN
53. Millon T. Millon clinical multiaxial inventory-II manual (1983), National Computer Systems, Minneapolis, MN
54. Millon T. Millon Clinical Multiaxial Inventory--III (1994), National Computer Systems, Inc, Minneapolis, MN
55. Newcombe D.A., Humeniuk R.E., and Ali R. Validation of the World Health Organization Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): Report of results from the Australian site. Drug and Alcohol Review 24 3 (2005) 217-226
56. Owen R.R., Fischer E.P., Booth B.M., and Cuffel B.J. Medication noncompliance and substance abuse among patients with schizophrenia. Psychiatric Services 47 8 (1996) 853-858
57. Petrakis I.L., O'Malley S., Rounsaville B., Poling J., McHugh-Strong C., and Krystal J.H. Naltrexone augmentation of neuroleptic treatment in alcohol abusing patients with schizophrenia. Psychopharmacology 172 3 (2004) 291-297
58. Riggs S.R., and Alario A. RAFFT questions. Project ADEPT manual (1987), Brown University
59. Rosenberg S.D., Drake R.E., Wolford G.L., Mueser K.T., Oxman T.E., Vidaver R.M., et al. Dartmouth Assessment of Lifestyle Instrument (DALI): A substance use disorder screen for people with severe mental illness. The American Journal of Psychiatry 155 2 (1998) 232-238
60. Rosenheck R. Mental health and substance abuse services for veterans: Experience with performance evaluation in the Department of Veterans Affairs. Prepared for the Institute of Medicine Committee on crossing the quality chasm: Adaptation for mental health and substance abuse (2004), VA Northeast Program Evaluation Center (NEPEC), Department of Veterans Affairs, New Haven, CT
61. Rouse S.V., Butcher J.N., and Miller K.B. Assessment of substance abuse in psychotherapy clients: The effectiveness of the MMPI-2 substance abuse scales. Psychological Assessment 11 (1999) 101-107
62. Saunders J.B., Aasland O.G., Babor T.F., de la Fuente J.R., and Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption-II. Addiction 88 6 (1993) 791-804
63. Saunders B., and Robinson S. Co-occurring mental health and drug dependency disorders: Work-force development challenges for the AOD field. Drug and Alcohol Review 21 3 (2002) 231-237
64. Schmitz J.M., Averill P., Sayre S., McCleary P., Moeller F.G., and Swann A. Cognitive-behavioral treatment of bipolar disorder and substance abuse: A preliminary randomized study. Addictive Disorders & Their Treatment 1 1 (2002) 17-24
65. Searles J.S., Alterman A.I., and Purtill J.J. The detection of alcoholism in hospitalized schizophrenics: A comparison of the MAST and the MAC. Alcoholism, Clinical and Experimental Research 14 4 (1990) 557-560
66. Selzer M.I., Vinokur A., and van Rooijen L. A self-administered Short Michigan Alcoholism Screening Test (SMAST). Journal of Studies on Alcohol 36 (1975) 117-126
67. Shaner A., Khalsa M.E., Roberts L., Wilkins J., Anglin D., and Hsieh S.C. Unrecognized cocaine use among schizophrenic patients. American Journal of Psychiatry 150 5 (1993) 758-762
68. Sheehan, D.V., Lecrubier, Y., Sheehan, K.H., Amorim, P., Janavs, J., Weiller, E., et al, Hergueta, T., Baker, R., & Dunbar, G.C., (1998). The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry, 59 Suppl 20, 22-33;quiz 34-57.
69. Skinner H.A. The drug abuse screening test. Addictive Behaviors 7 4 (1982) 363-371
70. Soderstrom C.A., Smith G.S., Dischinger P.C., McDuff D.R., Hebel J.R., Gorelick D.A., et al. Psychoactive substance use disorders among seriously injured trauma center patients. Jama 277 22 (1997) 1769-1774
71. Spitzer R.L., Williams J.B.W., Gibbon M., and First M.B. Instruction manual for the structured clinical interview for DSM-III-R (1988), State Psychiatric Institute, Biometrics Research, New York
72. Stein L.A.R., Graham J.R., Ben-Porath Y.S., and McNulty J.L. Using the MMPI-2 to detect substance abuse in an outpatient mental health setting. Psychological Assessment 11 (1999) 94-100
73. Sullivan E., and Fleming M. A guide to substance abuse services for primary care clinicians, Treatment Improvement Protocol (TIP) Series 24, DHHS Publication No. (SMA) 97-3139, U.S (1997), Department of Health and Human Services, SAMHSA, and Center for Substance Abuse Treatment, Rockville, MD
74. Svanum S., and McGrew J. Prospective screening of substance dependence: The advantages of directness. Addictive Behaviors 20 2 (1995) 205-213
75. Tarter R., and Hegedus A. The drug use screening inventory: Its applications in the evaluation and treatment of alcohol and drug abuse. Alcohol, Health, and Research World 15 (1991) 65-75
76. Tarter R.E., and Kirisci L. The drug use screening inventory for adults: Psychometric structure and discriminative sensitivity. American Journal of Drug and Alcohol Abuse 23 2 (1997) 207-219
77. Tiet Q.Q., Finney J., and Moos R. Recent sexual abuse, physical abuse, and suicide attempt among male patients seeking substance abuse treatment. Psychiatric Services 57 1 (2006) 107-113
78. Tiet Q.Q., Ilgen M., Byrnes H., Harris A.H.S., and Finney J. Treatment setting and baseline substance use severity interact to account for patients' outcomes. Addiction 102 (2007) 432-440
79. Tiet Q.Q., Ilgen M., Brynes H., and Moos R. Suicide attempts among substance use disorder patients: An initial step toward a decision tree for suicide management. Alcoholism: Clinical and Experimental Research 30 6 (2006) 998-1005
80. Tiet Q.Q., and Mausbach B. Treatments of patients with dual diagnosis: A review. Alcoholism: Clinical and Experimental Research 31 4 (2007) 513-536
81. Tonigan J.S., and Miller W.R. The inventory of drug use consequences (InDUC): Test-retest stability and sensitivity to detect change. Psychology of Addictive Behaviors 16 2 (2002) 165-168
82. Veterans Health Administration. FY05 VHA performance measure: 15 b. Substance use disorder (2004), Department of Veterans Affairs. Office of Quality and Performance, Washington, DC
83. Veterans Health Administration. The comprehensive VHA mental health strategic plan: aligned with the recommendations of the Action Agenda (AA) (2005), Department of Veterans Affairs, Washington, DC
84. Volkow N.D., Fowler J.S., Wolf A.P., Schlyer D., Shiue C.Y., Alpert R., et al. Effects of chronic cocaine abuse on postsynaptic dopamine receptors. American Journal of Psychiatry 147 6 (1990) 719-724
85. Weed N.C., Butcher J.N., McKenna T., and Ben-Porath Y.S. New measures for assessing alcohol and drug abuse with the MMPI-2: The APS and AAS. Journal of Personality Assessment 58 2 (1992) 389-404
86. Wolford G.L., Rosenberg S.D., Drake R.E., Mueser K.T., Oxman T.E., Hoffman D., et al. Evaluation of methods for detecting substance use disorder in persons with severe mental illness. Psychology of Addictive Behaviors 13 (1999) 313-326
87. World Health Organization. Schedules for clinical assessment in neuropsychiatry, Version 2.1: Interview, glossary and code book (1999), WHO: Devesion of Mental Health, Assessment, Classification and Epidemiology, Geneva
88. World Health Organization ASSIST Working Group. The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): development, reliability and feasibility. Addiction 97 9 (2002) 1183-1194